Vaccines
In this section you will find Therapeutics Line of Treatment Vaccines market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Cancer Vaccines Drug Pipeline Update 2012
€1,499.00Published by BioSeeker Group on Feb 21st, 2012BioSeeker Group have identified 215 companies plus partners who are today developing 241 cancer vaccine drugs in 499 developmental projects in cancer across 111 different targets. In addition, there are 6 suspended drugs and another 173 drugs where development has been ceased. Learn More -
Analytical Tool - Cancer Vaccines
€3,100.00Published by BioSeeker Group on Feb 21st, 2012The ultimate tool for serious players who would like to understand the current competitive field in cancer vaccine development. Learn More -
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics
€2,692.00Published by Kalorama Information on Jul 1st, 2011The line between drug delivery and drug substance will continue to become more elusive in the near future as shown in the analysis, as researchers work to improve drug properties... Learn More -
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
€3,230.00Published by Kalorama Information on Jul 1st, 2011The high growth rates and successful launch of several products recently has kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010... Learn More -
Pre-Filled Syringes: World Market Outlook 2011-2021
€1,968.00Published by Visiongain on Jun 21st, 2011... Learn More -
World Vaccines Market 2011-2021
€1,968.00Published by Visiongain on Jun 7th, 2011see which market areas will grow fastest Do you want to know how the vaccines industry and market will develop from 2011? Our new report shows you potential revenues to... Learn More -
Cancer Vaccines Markets
€2,720.00Published by TriMark Publications LLC on May 2nd, 2011Cancer vaccines have the potential to become a significant force in future cancer treatments. In 2010, Dendreon’s Provenge became the first cancer vaccine approved by the FDA, generating renewed interest... Learn More -
European Vaccine Markets
€2,303.00Published by Kalorama Information on Nov 1st, 2010The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and... Learn More -
Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025
€1,739.00Published by Visiongain on Sep 28th, 2010Where you can find opportunities in this market. Our new report will show you how the market for antithrombotic and anticoagulant drugs will develop. You can indentify where the greatest... Learn More -
Breast Cancer Vaccines and Therapeutic Antibodies: Current Pipeline and Emerging Immunotherapeutic Strategies, 2010
€1,750.00Published by BioPharm Reports on Sep 1st, 2010The breast cancer immunotherapy pipeline is showing rapid development. This report presents findings on more than 30 candidate therapies, including 22 therapeutic vaccines and 11 antibodies. Of the 22 vaccines... Learn More -
Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition
€3,072.00Published by Kalorama Information on Sep 1st, 2010Kalorama has been researching and examining the development of cancer vaccines for seven years. In April 2010, the cancer vaccine market experienced one of the largest achievements for therapeutic vaccine... Learn More -
Prostate Cancer: Vaccines and Therapeutic Antibodies, 2010
€1,750.00Published by BioPharm Reports on Aug 9th, 2010The prostate cancer immunotherapy pipeline is showing rapid development. Currently, there are 30 candidates in the pipeline (16 vaccines and 14 therapeutic antibodies), and one prostate cancer vaccine (Provenge®) has recently been approved by the FDA. Learn More -
Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
€3,072.00Published by Kalorama Information on Aug 1st, 2010Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies’ portfolios. They’ve... Learn More -
Alzheimer’s Disease Immunotherapy Pipeline: Vaccines, Therapeutic Antibodies and Emerging Strategies
€1,743.00Published by BioPharm Reports on Jul 16th, 2010Current drug treatments for Alzheimer’s Disease (AD) are dominated by two drug classes: the cholinesterase inhibitors (e.g. Aricept®) and, more recently, an NMDA receptor antagonist (e.g. Ebixa®). While these drugs... Learn More -
H1N1 Swine Flu Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
€3,100.00Published by Kalorama Information on May 3rd, 2010The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries... Learn More